"Designing Growth Strategies is in our DNA"

Structural Heart Devices Market Size, Share & Industry Analysis By Product (Instruments [Heart Value Devices, Occlusion & Closure Devices and Others] and Accessories), By Procedure Type (Valve Replacement Procedures [Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, and Others], Repair Procedures [Mitral Edge-to-Edge Repair, Tricuspid Edge-to-Edge Repair, and Others], Structural Heart Closure Procedures [Atrial Septal Defect Closure, Ventricular Septal Defect Closure, and Others]), By Indication, By End User, and Regional Forecast, 2026-2034

Last Updated: December 23, 2025 | Format: PDF | Report ID: FBI111600

 


To get information on various segments, share your queries with us

 

ATTRIBUTE 

DETAILS

Study Period

2021-2034

Base Year

2025

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 7.2% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Product, Procedure Type, Indication, End User, and Region

By Product

·       Instruments

o   Heart Valve Devices

o   Occlusion & Closure Devices

o   Others

·       Accessories

By Procedure Type

·       Valve Replacement Procedures

o   Transcatheter Aortic Valve Replacement (TAVR)

o   Transcatheter Mitral Valve Replacement (TMVR)

o   Others

·       Repair Procedures

o   Mitral Edge-to-Edge Repair

o   Tricuspid Edge-to-Edge Repair

o   Others

·       Structural Heart Closure Procedures

o   Atrial Septal Defect closure

o   Ventricular Septal Defect closure

o   Others

By Indication

·       Heart Valve Diseases

·       Congenital Heart Defects

·       Others

By End User

·       Hospitals & ASCs

·       Specialty Clinics

·       Others

By Region

·       North America (By Product, By Procedure Type, By Indication, By End User, and by Country)

o   U.S. (By Indication)

o   Canada (By Indication)

·       Europe (By Product, By Procedure Type, By Indication, By End User, and by Country/Sub-region)

o   U.K. (By Indication)

o   Germany (By Indication)

o   France (By Indication)

o   Italy (By Indication)

o   Spain (By Indication)

o   Scandinavia (By Indication)

o   Rest of Europe (By Indication)

·       Asia Pacific (By Product, By Procedure Type, By Indication, By End User, and by Country/Sub-region)

o   China (By Indication)

o   Japan (By Indication)

o   India (By Indication)

o   Australia (By Indication)

o   Southeast Asia (By Indication)

o   Rest of Asia Pacific (By Indication)

·       Latin America (By Product, By Procedure Type, By Indication, By End User, and by Country/Sub-region)

o   Brazil (By Indication)

o   Mexico (By Indication)

o   Rest of Latin America (By Indication)

·       Middle East & Africa (By Product, By Procedure Type, By Indication, By End User, and by Country/Sub-region)

o   GCC (By Indication)

o   South Africa (By Indication)

o   Rest of the Middle East & Africa (By Indication)

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann